ChartRow logo
CAI
$31.11+1.30%
as of close, Oct 20, 2026
☾ AH $31.11 +1.30%
Share this page

Caris Life Sciences Inc. monthly returns

Caris Life Sciences Inc. has averaged 3.48% per month, positive in 50% of months. Month-by-month returns for Caris Life Sciences Inc. (CAI) below, through October 20, 2026 — the table lists the most recent months; the bar chart plots the last 5 years.

Average month
+3.5%
10 months
Best month
+62.7%
Aug 2026
Worst month
-14.2%
Jan 2026
Positive months
50%
of all months

Caris Life Sciences Inc. monthly returns#

Caris Life Sciences Inc. total return by month
MonthTotal return
Oct 2026
+1.6%
Sep 2026
+20.2%
Aug 2026
+62.7%
Jul 2026
-12.1%
Jun 2026
+6.6%
May 2026
-12.0%
Apr 2026
+6.3%
Mar 2026
-11.2%
Feb 2026
-13.0%
Jan 2026
-14.2%
Dec 2025
+5.7%
Nov 2025
-15.1%
Oct 2025
-0.6%
Sep 2025
-21.2%
Aug 2025
+36.7%
Jul 2025
+5.1%

Monthly total return (since Jan 2026)#

Caris Life Sciences Inc. returns by calendar month#

Every month of every year since 2026, one tick per year on a shared scale; the dark bar is the month's average. Total returns, dividends reinvested.

October 2026 so far: +1.57% — 1st of 1 Octobers since 2026 at the last close; the average October returned —.

Caris Life Sciences Inc. returns by calendar month since 2026
Month−65%0+65%AverageUp
Jan-14.2%0%
Feb-13.0%0%
Mar-11.2%0%
Apr+6.3%100%
May-12.0%0%
Jun+6.6%100%
Jul-12.1%0%
Aug+62.7%100%
Sep+20.2%100%
OctOctober 2026 so far: +1.6%——
Nov——
Dec——

Methodology#

Monthly returns are total returns (dividends reinvested), computed from CAI's split- and dividend-adjusted month-end closes. The table shows the most recent 120 months and the bar chart the most recent 60. See the year-by-year returns for the annual view. Past performance does not predict future returns; not investment advice.

FAQ#

What is Caris Life Sciences Inc.'s average monthly return?
Caris Life Sciences Inc. (CAI) has averaged about 3.48% per month, positive in roughly 50% of months. The best month was Aug 2026 (+62.7%) and the worst was Jan 2026 (-14.2%).

More on Caris Life Sciences Inc.